News | September 11, 2023
SÜDPACK Medica presents PharmaGuard at CPHI in Barcelona
SÜDPACK customers also benefit when it comes to processing PharmaGuard
SÜDPACK customers also benefit when it comes to processing PharmaGuard
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
The PP-based top and bottom webs are manufactured in a unique coextrusion process
These initiatives aim to improve access to healthcare for rare disease patients
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
SÜDPACK is setting standards in terms of both performance and sustainability
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
